This webinar is for UK HCPs only and has been developed and organised by Seqirus.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events relating to Seqirus products should also be reported to Seqirus UK Limited on 01748 828816.
Click below for prescribing information;
Flucelvax® Tetra , Influenza vaccine (surface antigen, inactivated, prepared in cell cultures) prescribing information https://labeling.seqirus.com/API/UK/Flucelvax-Tetra/EN/Flucelvax-Tetra-Prescribing-Information.pdf